G. Krzentowski

Risk of Developing Retinopathy in Diabetes Control and Complications Trial Type 1 Diabetic Patients With Good or Poor Metabolic Control

LiYing Zhang, G. Krzentowski, Adelin Albert et al. · Diabetes Care · 2001 · 257 citations · Full text

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

The Gene INPPL1, Encoding the Lipid Phosphatase SHIP2, Is a Candidate for Type 2 Diabetes In Rat and Man

Evelyne Marion, Pamela J. Kaisaki, Valérie Pouillon et al. · Diabetes · 2002 · 129 citations · Full text

Genetics, Insulin Signaling, Metabolic Syndrome +20

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Katelijn Decochez, Jos Tits, Jean-Luc Coolens et al. · Diabetes Care · 2000 · 107 citations · Full text

Fate of exogenous glucose during exercise of different intensities in humans

F Pirnay, Jean-Michel Crielaard, N. Pallikarakis et al. · Journal of Applied Physiology · 1982 · 93 citations

Physical Activity, Different Intensities, Oral Load +18